Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: MRR

Healthcare Hyperspectral Imaging (HSI) Systems Market to Record a CAGR of 16.41%, North America to Contribute Majority of Market Growth - Technavio


NEW YORK, Aug. 19, 2022 /PRNewswire/ -- The healthcare hyperspectral imaging (HSI) systems market will be driven by the increasing awareness coupled with safety and ease of use of systems. However, factors such as high investment and installation costs may challenge market growth.

The healthcare hyperspectral imaging (HSI) systems market size is expected to grow by USD 163.84 mn from 2020 to 2025. In addition, the growth momentum of the market will accelerate at a CAGR of 16.41% during the forecast period, according to Technavio.

To get an up-to-date analysis as well as the exact Y-O-Y growth rate, Request a FREE PDF sample report.

Healthcare Hyperspectral Imaging (HSI) Systems Market 2021-2025:Scope

The healthcare hyperspectral imaging (HSI) systems market report covers the following areas:

Healthcare Hyperspectral Imaging (HSI) Systems Market 2021-2025:Vendor Analysis

The healthcare hyperspectral imaging (HSI) systems market is fragmented, and the vendors are deploying organic and inorganic growth strategies to compete in the market. Applied Infrared Sensing, BaySpec Inc., Corning Inc., Galileo Group Inc., Gooch and Housego Plc, Headwall Photonics Inc., imec VZW, Konica Minolta Inc., Norsk Elektro Optikk AS, and Resonon Inc. are some of the major market participants. The key offerings of a few of these vendors are listed below:

Healthcare Hyperspectral Imaging (HSI) Systems Market 2021-2025:Segmentation

Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a FREE PDF Sample Report

Healthcare Hyperspectral Imaging (HSI) Systems Market 2021-2025:Key Highlights
Related Reports

Cardiovascular Ultrasound Imaging Systems Market by Product and Geography - Forecast and Analysis 2022-2026

Multimodal Imaging Market by Application and Geography - Forecast and Analysis 2022-2026

Healthcare Hyperspectral Imaging (HSI) Systems Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 16.41%

Market growth 2021-2025

USD 163.84 million

Market structure

Fragmented

YoY growth (%)

18.97

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 40%

Key consumer countries

US, Germany, China, France, and UK

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Applied Infrared Sensing, BaySpec Inc., Corning Inc., Galileo Group Inc., Gooch and Housego Plc, Headwall Photonics Inc., imec VZW, Konica Minolta Inc., Norsk Elektro Optikk AS, and Resonon Inc.

Market Dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse Health Care Market Reports

Table Of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Five Forces Analysis

5 Market Segmentation by Product

6 Customer landscape

7 Geographic Landscape

8 Drivers, Challenges, and Trends

9 Vendor Landscape

10 Vendor Analysis

11 Appendix

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
Newsroom: newsroom.technavio.com/news/healthcare-hyperspectral-imaging-hsi-systemsmarket

SOURCE Technavio


These press releases may also interest you

at 08:20
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has launched its Laboratory Automation Provider Program, enabling automation providers to readily support the adoption of Parse's...

at 08:15
Seed Health, a microbiome science company, today announced the appointment of Zain Kassam, M.D., M.P.H., as Chief Medical Officer. An award-winning physician-scientist, Dr. Kassam has played a pivotal role in the advancement of microbiome science for...

at 08:10
bioAffinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, today announced David Elzi, Ph.D., has been named Vice President of...

at 08:10
Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") today announced the availability of Over the Counter ("OTC") Naloxone Hydrochloride (Naloxone HCI) Nasal Spray, USP, 4mg, following Abbreviated New Drug Application ("ANDA") approval from the...

at 08:10
BigHat Biosciences, a biotechnology company with an artificial intelligence/machine learning-guided antibody discovery and development platform announced a collaboration with Janssen Biotech Inc., a Johnson & Johnson company. This strategic...

at 08:10
Kiromic BioPharma, Inc. ("Kiromic" or the "Company") announces consistent favorable safety, tolerability, and efficacy from follow-up visits of the first cohort of three patients enrolled in the Company's Deltacel-01 Phase 1 clinical trial....



News published on and distributed by: